cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Syndax Pharmaceuticals
2 own
7 watching
Current Price
$14.26
$-0.15
(-1.04%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,607.47M
52-Week High
52-Week High
25.34000
52-Week Low
52-Week Low
12.060000
Average Volume
Average Volume
0.99M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,607.47M
icon52-Week High25.34000
icon52-Week Low12.060000
iconAverage Volume0.99M
iconDividend Yield--
iconP/E Ratio--
What does the Syndax Pharmaceuticals do?
Developing a therapy that enhances checkpoint immuno-oncology drugs.
Read More
How much money does Syndax Pharmaceuticals make?
News & Events about Syndax Pharmaceuticals.
TipRanks Financial Blog
1 year ago
In a report released yesterday, Madhu Kumar from Goldman Sachs reiterated a Buy rating on Syndax Pharmaceuticals (SNDX Research Report). The comp... In a report released yesterday, Madhu Kumar from Goldman Sachs reiterated a Buy rating on Syndax Pharmaceuticals (SNDX &#8211...
PR Newswire
1 year ago
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Syndax Pharmaceuticals, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Syndax Pharmaceuticals, Inc. for Potential Breaches of Fiduciary...
Ticker Report
2years ago
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX Get Rating) has received an average recommendation of Moderate Buy from the seven ratings firms that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell rating and four have assigned...
PR Newswire
2years ago
Syndax Announces Pricing of $150 Million Public Offering of Common Stock Syndax Announces Pricing of $150 Million Public Offering of Common Stock PR Newswire WALTHAM, Mass., Dec. 6, 2022 WALTHAM, Mass., Dec. 6, 2022 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. ('Syndax,' the...
Frequently Asked Questions
Frequently Asked Questions
What is Syndax Pharmaceuticals share price today?
plus_minus_icon
Can Indians buy Syndax Pharmaceuticals shares?
plus_minus_icon
How can I buy Syndax Pharmaceuticals shares from India?
plus_minus_icon
Can Fractional shares of Syndax Pharmaceuticals be purchased?
plus_minus_icon
What are the documents required to start investing in Syndax Pharmaceuticals stocks?
plus_minus_icon
What is today’s traded volume of Syndax Pharmaceuticals?
plus_minus_icon
What is today’s market capitalisation of Syndax Pharmaceuticals?
plus_minus_icon
What is the 52-Week High and Low Range of Syndax Pharmaceuticals?
plus_minus_icon
What percentage is Syndax Pharmaceuticals down from its 52-Week High?
plus_minus_icon
What percentage is Syndax Pharmaceuticals up from its 52-Week Low?
plus_minus_icon
Current Price
$14.26
$-0.15
(-1.04%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
NURIX THERAPEUTICS INC
NURIX THERAPEUTICS INC
$19.95
$-0.01 (-0.05 %)
Bicycle Therapeutics PLC
Bicycle Therapeutics PLC
$12.95
$-0.28 (-2.12 %)
Arcus Biosciences Inc
Arcus Biosciences Inc
$13.16
$-0.17 (-1.28 %)
Harmony Biosciences Holdings Inc
Harmony Biosciences Holdings Inc
$37.99
$-0.01 (-0.04 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
NURIX THERAPEUTICS INC
NURIX THERAPEUTICS INC
$19.95
$-0.01 (-0.05 %)
Bicycle Therapeutics PLC
Bicycle Therapeutics PLC
$12.95
$-0.28 (-2.12 %)
Arcus Biosciences Inc
Arcus Biosciences Inc
$13.16
$-0.17 (-1.28 %)
Harmony Biosciences Holdings Inc
Harmony Biosciences Holdings Inc
$37.99
$-0.01 (-0.04 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00